These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18980018)

  • 21. Carcinoembryonic antigen (CEA) mimicry by an anti-idiotypic scFv isolated from anti-Id 6.C4 hybridoma.
    Pignatari GC; Takeshita D; Parise CB; Soares FA; de Moraes JZ; Han SW
    J Biotechnol; 2007 Jan; 127(4):615-25. PubMed ID: 16989916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
    Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
    Front Immunol; 2019; 10():704. PubMed ID: 31031746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).
    Tada M; Tatematsu K; Ishii-Watabe A; Harazono A; Takakura D; Hashii N; Sezutsu H; Kawasaki N
    MAbs; 2015; 7(6):1138-50. PubMed ID: 26261057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
    Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial expression of a single-chain antibody fragment (SCFV) that neutralizes the biological activity of human interferon-gamma.
    Froyen G; Ronsse I; Billiau A
    Mol Immunol; 1993 Jun; 30(9):805-12. PubMed ID: 8321246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen.
    Stewart LM; Young S; Watson G; Mather SJ; Bates PA; Band HA; Wilkinson RW; Ross EL; Snary D
    Cancer Immunol Immunother; 1999 Feb; 47(6):299-306. PubMed ID: 10203059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
    Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.
    Kuroki M; Yamada H; Shibaguchi H; Hachimine K; Hirose Y; Kinugasa T; Ishida I; Kuroki M
    Anticancer Res; 2005; 25(6A):3733-9. PubMed ID: 16302733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Construction and expression of single chain variable fragments (ScFv) against human CD19 antigen].
    Chen S; Rao Q; Wang JX; Wang M
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):686-91. PubMed ID: 16285505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
    Guettinger Y; Barbin K; Peipp M; Bruenke J; Dechant M; Horner H; Thierschmidt D; Valerius T; Repp R; Fey GH; Stockmeyer B
    J Immunol; 2010 Feb; 184(3):1210-7. PubMed ID: 20042573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and expression of a single chain Fv fragment against pharmacologically active paeoniflorin in Escherichia coli, and its potential use in an enzyme-linked immunosorbent assay.
    Lu Z; Masaki T; Shoyama Y; Tanaka H
    Planta Med; 2006 Feb; 72(2):151-5. PubMed ID: 16491451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells.
    Hombach A; Schneider C; Sent D; Koch D; Willemsen RA; Diehl V; Kruis W; Bolhuis RL; Pohl C; Abken H
    Int J Cancer; 2000 Oct; 88(1):115-20. PubMed ID: 10962448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
    Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P
    J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Construction of anti-H5N1 virus chimeric igA antibody gene and its expression in CHO cells].
    Zhang B; Zhang X; Chen W; Liu D; Wang S; An X; Ran D; Zhao G; Zhou Y; Tong Y
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):714-9. PubMed ID: 19670640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
    Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
    Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA.
    Kuroki M; Arakawa F; Khare PD; Kuroki M; Liao S; Matsumoto H; Abe H; Imakiire T
    Anticancer Res; 2000; 20(6A):4067-71. PubMed ID: 11131674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.